The major internal protein, p30, of rat type C virus (RaLV) was purified and utilized to establish intra-and interspecies radioimmunoassays. Three rat viruses were compared in homologous and heterologous intraspecies assays with no evidence of type specificity. The only heterologous viruses to give inhibition in these species assays were the feline (FeLV) and hamster (HaLV) type C viruses; these reactions were incomplete and required high virus concentrations. An interspecies assay using a goat antiserum prepared after sequentially immunizing with FeLV, RD 114, and woolly monkey virus p30's and labeled RaLV p30 was inhibited by all mammalian type C viruses, although preferentially by RaLV, FeLV, and HaLV. Thus, as in a previously reported assay developed with HaLV p30, rat, hamster, and cat p30's seem more closely related to each other than to mouse type C virus p30. High levels of specific antigen were found in all cell lines producing rat virus, whereas embryonic tissues from several rat strains and cell lines considered virus-free based on other tests were negative for p30. Rats bearing tumors containing Moloney murine sarcoma virus (RaLV) did not contain free circulating antibody to RaLV p30. Fifty-one human tumor extracts (including two tumor cell lines) were tested for activity in the RaLV species and 47 in the interspecies assays after Sephadex gel filtration and pooling of material in the 15,000-to 40,000-molecular-weight range. At a sensitivity level of 7 ng/ml (0.7 ng/assay) in the interspecies assay, all human tissues, with one exception, were negative. The one positive result is considered nonspecific based on proteolysis of the labeled antigen. Input tissue protein of the purified tumor extracts averaged 1.9 mg/ml with a range of <0.025 to 22 mg/ml. Tissues from NIH Swiss mice processed in the same manner were positive in the interspecies assay but negative in the intraspecies RaLV assay.
The major internal protein, p30, of rat type C virus (RaLV) was purified and utilized to establish intra-and interspecies radioimmunoassays. Three rat viruses were compared in homologous and heterologous intraspecies assays with no evidence of type specificity. The only heterologous viruses to give inhibition in these species assays were the feline (FeLV) and hamster (HaLV) type C viruses; these reactions were incomplete and required high virus concentrations. An interspecies assay using a goat antiserum prepared after sequentially immunizing with FeLV, RD 114, and woolly monkey virus p30's and labeled RaLV p30 was inhibited by all mammalian type C viruses, although preferentially by RaLV, FeLV, and HaLV. Thus, as in a previously reported assay developed with HaLV p30, rat, hamster, and cat p30's seem more closely related to each other than to mouse type C virus p30. High levels of specific antigen were found in all cell lines producing rat virus, whereas embryonic tissues from several rat strains and cell lines considered virus-free based on other tests were negative for p30. Rats bearing tumors containing Moloney murine sarcoma virus (RaLV) did not contain free circulating antibody to RaLV p30. Fifty-one human tumor extracts (including two tumor cell lines) were tested for activity in the RaLV species and 47 in the interspecies assays after Sephadex gel filtration and pooling of material in the 15,000-to 40,000-molecular-weight range. At a sensitivity level of 7 ng/ml (0.7 ng/assay) in the interspecies assay, all human tissues, with one exception, were negative. The one positive result is considered nonspecific based on proteolysis of the labeled antigen. Input tissue protein of the purified tumor extracts averaged 1.9 mg/ml with a range of <0.025 to 22 mg/ml. Tissues from NIH Swiss mice processed in the same manner were positive in the interspecies assay but negative in the intraspecies RaLV assay.
The radioimmunoassay (RIA) procedure has been widely used in recent years as a measure of interviral relatedness and in the search for viral gene products in cell lines and tissues. In the case of mammalian type C virus p30, use of this technique gave the first evidence of heterogeneity of interspecies determinants (29) , which, along with species-specific determinants, are associated with this major internal virion protein (14) . Heterogeneity of determinants of both classes on individual molecules (7, 8) and between p30's of different species is now a well recognized phenomenon (4, 15, 29, 31, 35, 38, 40) . Among the murine leukemia viruses, p30 type-specific differences have also been reported (27, 38) ; these can be correlated with differences in primary structure (27) .
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We previously reported RIA for hamster (HaLV) type C virus p30 which indicated a relationship among feline (FeLV) and rat (RaLV) p30's which appeared closer than seen with murine (MuLV) virus p30 (4) . To continue these studies and evaluate possible typespecific differences among rat viruses, including an interspecies pseudotype, homologous and heterologous intraspecies and interspecies radioimmune assays have been developed. These assays were also utilized to test a variety of tissue culture cell lines and embryonic rat tissues for presence of p30.
In addition, these assays were utilized to test a number of human tumor extracts for p30 activity. Postive findings have previously been reported using other species-specific and interspecies RIA (36, 39) . The current procedures incorporated an inhibitor of proteolytic enzyme 51 activity; this activity is a potential technical problem in tissue assays leading to false positive results.
MATERIALS AND METHODS
Virus. The purification of banded virus and the isolation of the major structural protein, p30, by isoelectric focusing have been previously reported (24, 26) .
Radioimmunoprecipitation assays. Radioimmunoprecipitation assays were performed using a salt precipitation procedure as previously reported (5) and recently modified (6) . Competition RIA were performed by the salt technique and also with comparable results (except for tissue extracts) by a double antibody system similar to the technique developed by Parks and Scolnick (29) . The salt technique, although suitable for purified protein or whole disrupted virus, has certain inherent technical limitations when used with tissue extracts. Phenylmethanesulfonyl fluoride (Pierce Chemicals) was added to incubation mixtures at a final concentration of 300 lsg/ml to inhibit proteolytic digestion of the radioactive p30 during the incubation period (9) . The conditions of the competition assay were: 100 gl of labeled RaLV p30 diluted in 0.01 M Tris-hydrochloride, pH 7.4, with 0.15 M NaCl containing 2% bovine serum albumin (BSA); 100 pl of inhibiting proteins in the same buffer containing 0.2% BSA and 100 ul of specific immune serum diluted in 1% normal carrier serum at a dilution sufficient to bind about 50% of input radioactivity were incubated for 3 h at 37 C and overnight at 4 C. Anti-species antibody (either goat anti-guinea pig or rabbit anti-goat gamma globulin) (100 4l) was then added at a dilution sufficient to maximally precipitate the initial complex. Tubes were incubated at 37 C for 2 h and at 4 C for 3 h and then centrifuged 30 min at 4,000 rpm in a Sorvall RC 2B centrifuge equipped with HS4 swinging bucket rotors. Tubes were inverted on absorbent paper, residual fluid was removed from the mouth of each tube with a cotton-tipped swab, and precipitate radioactivities were determined in a Nuclear model 1185 automatic gamma counter with a calculated efficiency for a simulated 1251 standard (Nuclear-Chicago) of 79 to 80%.
Labeled antigens. Purified RPL-RaLV p30 was labeled with 125I using the chloramine T procedure (16) . Free and protein-bound radioactivity were separated by initial overnight dialysis at 4 C. At (20) . The origin and properties of the B-34 cell, a transformed hamster cell shedding the HaLV pseudotype of Harvey sarcoma virus, have been discussed (1, 4, 42) . Harvey sarcoma virus was derived from rat passage of Moloney MuLV (17) , and this is reflected in the presence of RaLV sequences in addition to MuLV sequences in the viral genome (33) . A partial analysis of the immunologic properties of HaLV p30 has been previously reported (4) . The 78A1 cell line is a rat cell productively transformed with M-MSV (3).
Protein estimations. The protein content of 20% tissue extracts was estimated by the method of Lowry et a1. (21) using crystalline BSA as standard (Armou).
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis was performed using precast 12% gels (Biophor, Bio-Rad) according to the method of Weber and Osborne (44) . Molecular weights were estimated by linear regression analysis of the log10 molecular weights of the indicated standards versus mobility relative to the low-molecular-weight marker bromophenol blue: BSA, 68,000; ovalbumin, 43,000; carbonic annhydrase, 29,000; lysozyme, 14,300.
Preparation of rat embryo extracts. Eighteenday embryos were obtained from six strains of pregnant rats purchased from Microbiological Associates, Bethesda, Md. Twenty percent (wt/vol) aqueous extracts were made from individual embryos as previously published (4). Phenylmethanesulfonyl fluoride (PMSF), obtained from Pierce Chemical Co., was incorporated in the diluent buffer and was prepared as follows: crystalline PMSF was dissolved in dimethyl sulfoxide (ME2SO) at a concentration of 200 mg/ml, diluted in 0.01 M Tris-hydrochloride (pH 7.4) containing 0.15 NaCl to a final concentration of 300 jg/ml, and then incubated at 37 C for 1 Inoculation of rats with M-MSV (RaLV)-producing rat cells. Twenty weanling Brown-Norway rats were inoculated with a single 0.3-ml subcutaneous dose of 0.3 ml of MSV-1 cells shedding M-MSV (RaLV) preinoculation sera, and sera obtained after 1 and 2 weeks were titrated for anti-RaLV p30 antibodies.
RESULTS
Purity of RaLV p30. The 125I-labeled RPLRaLV p30 preparation migrated as a single radioactive zone when electrophoresed on 12% sodium dodecyl sulfate-polyacrylamide gels. (Fig. 1) . Neither higher-nor lower-molecularweight contaminants were observed, even with input radioactivities of 300,000 to 700,000 counts/min per gel. were electrophoresed according to the text and references 4 and 44. After staining and destaining, gels were sliced into 80 1-mm slices with a mechanical razor blade device (Bio-Rad), and the radioactivity of individual slices was determined. The molecular weight (MW) of 28,900 ± 2,700 was obtained by linear regression analysis of the log,0 molecular weight of the following internal standards versus mobility relative to the tracking dye: BSA, 68,000; ovalbumin, 43,000; carbonic annhydrase, 29,000; lysozyme, 14,300. This value is in general agreement with the reported value for M-MSV (RaLV) of 27,000 (24) . Even though the apparent molecular weight is less than 30,000, this protein will be referred to as p30 to indicate homology among this class of proteins in various mammalian type C viruses.
Antibody precipitability. Greater than 80% of input radioactivity was specifically precipitated at a 1:1,000 dilution of each hyperimmune serum. Binding titers (50%) were 1:5,000 for the homologous rabbit anti RPL-RaLV serum, 1:50,000 to 200,000 for the guinea pig anti M-MSV (RaLV) serum, and 1:50,000 for the interspecies goat serum.
Since we had titrated the guinea pig serum against the homologous M-MSV (RaLV) p30 1 year previous to the current experiments, it is noteworthy that 50% binding titers against the heterologous RPL p30 differed by less than a factor of 2 from the original results, indicating a high degree of similarity between the p30's from these virus strains.
Competition RIA. Figure 2A The homologous RIA was 16-to 50-fold and both heterologous assays roughly 100-fold more sensitive than complement fixation (CF) tests on the same preparation.
p30 in rat and other cells. Once the sensitivity and specificity of the assays had been established, a variety of virus-producing and control cultures were tested for RaLV p30. p30 was generally detected in high levels only in those cells known to be shedding RaLV (Table  1) . Uninfected rat cells, or cells producing other non-rat type C viruses, did not cross-react in the intraspecies assays. Thus, an XC subline producing low levels of RaLV (detected initially in the CF test) contained 120 ng of p30 per mg of cell protein. The RPL cell line used for virus production had the highest observed levels, 6 (Table 2) at input protein levels similar to those assayed from cultured RaLV-negative cells.
Lack of RaLV p30 antibodies in rats bearing M-MSV (RaLV) tumors. Geering et al. (10) obtained antisera to MuLV p30 from rats bearing MuLV-induced leukemia. These sera were found to cross-react with FeLV and subsequent type C virus isolates, including RaLV p30 (11) . Antisera to MuLV p30 were also found in rats bearing transplant sarcomas induced by MSV (19) . We made a limited study of the response of Brown-Norway rats inoculated with tumor transplants of the homologous MSB-1 labeled RPL RaLV p30 anti M-MSV (RaLV).°2 0% inhibition in undiluted extract, negative at 1:2 dilution. This result is considered marginal. type of MSV do not form RaLV p30 antibodies. Human tumors. Tissue extracts were purified an average of 44-fold after G-100 chromatography and concentration by ultrafiltration.
All samples were negative in highly specific CF tests for RaLV, FeLV, MuLV, RD 114, HaLV, and GaLV p30's and negative in a broadly reacting CF test recognizing all known mammalian virus p30's. All but one of the concentrates were negative in both intra-and interspecies RaLV p30 assays at levels of 0.6 to 0.8 ng of RaLV p30 per mg of cellular protein after consideration of purification factors. The single sample producing positive inhibition was an apparently normal autopsy spleen from a patient with pancreatic carcinoma. This concentrate gave positive reactions in both the homologous intraspecies (10% inhibition titer = 1:2, maximal inhibition = 40%) and heterologous interspecies assay (titer = 1:2, 23% inhibition). This same extract gave comparable or higher inhibitory activity in highly specific FeLV, GaLV, and MuLV p30 RIAs and produced complete inhibition with an end point still not reached ('80% inhibition) at 1:128 dilution in an interspecies assay with 125I_ labeled RD 114 p30. The latter result was striking since the known sensitivity of the interspecies RIA relative to the CF test would have demanded a CF titer of at least 1:8 if the RIA results were immunologically specific. This was not observed.
Therefore, we suspected false positive results related to degradation of RaLV p30 by tissue proteases co-purified in the 30,000-dalton fractions. This was confirmed by demonstrating the liberation of trichloroacetic acid-soluble fragments when 1251-labeled RaLV p30 was incubated with the concentrate at 37 C according to standard RIA procedure, but not when all incubations were done at 4 C ( Table 4) . We have previously found this technique to be a precise but minimal estimate of the digestion of MuLV p30 (7) .
The NIH Swiss spleen extracts gave positive results in the interspecies assay (Table 5) and not the RaLV species assays. This verifies that the purification procedure is suitable for tissue extracts which, based upon extensive studies (19, 28) , were known to be p30 positive. The specificity of these tissue concentrates was as predicted by studies of type C viruses from mice and rats.
Full details of attempts to detect p30 determinants of various specificities in human tissues will be presented elsewhere. DISCUSSION The RIA procedure first gave evidence of the heterogeneity of p30 interspecies determinants when RD 114 and WoLV-GaLV were observed to give only partial inhibition of an assay using labeled mouse p30 and anti-FeLV p30 (29) . Based on data from a variety of studies, including reverse transcriptase inhibition by antibody, molecular hybridization, and p30 amino terminal sequence comparisons, there seem to be three clear subgroups of mammalian type C viruses (12, 13, 25) . These are (i) WoLV-GaLV, (ii) RD 114-baboon, and (iii) MuLV, RaLV, FeLV, HaLV. We previously noted that an interspecies assay using labeled HaLV p30 was only partially inhibited by MuLV, whereas FeLV and RaLV gave complete inhibition (4) . Similarly, our colleague (S. Oroszlan) has noted that an interspecies reactive serum prepared against FeLV, after specific purification on an HaLV immunoabsorbent, produced identity reactions between HaLV, RaLV, and FeLV but clear partial identity with MuLV compared to these antigens. The current data show that the species-specific assay for RaLV is inhibited to a slight degree by FeLV and HaLV and not MuLV and also that the interspecies assay with labeled RaLV is incompletely inhibited by MuLV. Thus, MuLV p30 appears to be more distantly related to the other members of its subgroup than they are to one another.
We have previously noted that serologic data do not support a simple concept of coevolution of RNA tumor viruses and host genes (12, 13 VOL. 17, 1976 .58 are products of homologous genes based on both immunologic and sequence data (25) , and that ancestral genes of contemporary viruses must have existed in mammals prior to the times suggested for the horizontal transmission events.
The current p30 RIA also failed to demonstrate any type-specific differences among the RaLV p30's as also recently noted by others (32) . Certain of these viruses are interspecies pseudotypes based on nucleic acid sequence relationships; however, only the rat p30 determinants are detected as previously seen in gel diffusion and CF tests. In these viruses p30 species type is correlated with the intracellular presence of a 35S subunit RNA corresponding to the helper virus. Similar findings were found with interspecies pseudotypes expressing hamster p30 (42) .
In contrast to results obtained in the mouse (19, 28) and hamster (4), we thus far have not found evidence of RaLV p30 in embryo extracts of several rat strains. Since the respective. assays were of similar sensitivity, there are evidently quantitative or qualitative differences in levels of expression in different species.
As part of a continuing effort to detect type C viral gene products in human tumors, we have applied the RaLV p30 species and interspecies assays to human tumor extracts nonspecifically purified by gel filtration. With care taken to avoid proteolysis of the labeled probe, these assays gave clear negative results with all but one of a large series of human tumors under conditions where NIH Swiss mouse tissues and an FeLV-producing cell line gave positive results in the interspecies assay. The single exception also gave positive inhibition in the rat and other species-specific assays. This sample degraded labeled p30 under assay conditions; thus, the apparent positive results are explained by proteolysis. Use of a single inhibitor, although extremely useful, would not be expected to control for the multiplicity of proteolytic enzymes present in tissue extracts.
